InsiderClue
Insiders · Profile

Szot Matthew K

Chief Financial Officer at Cadrenal Therapeutics · Director at INVO Fertility · Director at SenesTech. Filing since 1 Jun 2022. CIK 0001401385

CVKD Cadrenal Therapeutics, Inc. Chief Financial Officer · 12 trades IVF INVO Fertility, Inc. Director · 2 trades SNES SenesTech, Inc. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
CVKD Cadrenal Therapeutics, Inc.
29 Dec 2025
Chief Financial Officer
Sold on a plan
9,933
$69.23K
100%
IVF INVO Fertility, Inc.
3 Dec 2025
Director
Sold at will
4
$6.08
57.1%
SNES SenesTech, Inc.
14 Nov 2025
Director
Sold at will
1
$2.75
100%
CVKD Cadrenal Therapeutics, Inc.
27 Oct 2025
Chief Financial Officer
Sold on a plan
1,800
$25.18K
15.3%
CVKD Cadrenal Therapeutics, Inc.
24 Oct 2025
Chief Financial Officer
Sold on a plan
1,800
$25.18K
13.3%
CVKD Cadrenal Therapeutics, Inc.
13 Oct 2025
Chief Financial Officer
Sold on a plan
1,800
$25.33K
11.7%
CVKD Cadrenal Therapeutics, Inc.
9 Oct 2025
Chief Financial Officer
Sold on a plan
1,693
$23.69K
9.9%
CVKD Cadrenal Therapeutics, Inc.
6 Oct 2025
Chief Financial Officer
Sold on a plan
107
$1.50K
0.6%
CVKD Cadrenal Therapeutics, Inc.
1 Oct 2025
Chief Financial Officer
Sold on a plan
1,700
$23.78K
9.0%
CVKD Cadrenal Therapeutics, Inc.
29 Sep 2025
Chief Financial Officer
Sold on a plan
100
$1.40K
0.5%
CVKD Cadrenal Therapeutics, Inc.
25 Sep 2025
Chief Financial Officer
Sold on a plan
10,900
$153.18K
36.5%
CVKD Cadrenal Therapeutics, Inc.
24 Sep 2025
Chief Financial Officer
Sold on a plan
1,500
$20.99K
4.8%
CVKD Cadrenal Therapeutics, Inc.
28 Aug 2025
Chief Financial Officer
Sold on a plan
400
$5.60K
1.3%
CVKD Cadrenal Therapeutics, Inc.
27 Aug 2025
Chief Financial Officer
Sold on a plan
1,600
$22.39K
4.8%
IVF INVO Fertility, Inc.
1 Jun 2022
Director
Bought
14,474
$13.75K
58.6%
15 decisions on file.